OPKOPKO HEALTH, INC.

Nasdaq opko.com


$ 1.28 $ 0.02 (1.59 %)    

Friday, 10-May-2024 15:59:36 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 1.28
$ 1.28
$ 0.00 x 0
$ 0.00 x 0
$ 1.24 - $ 1.28
$ 0.85 - $ 2.24
2,103,072
na
892.15M
$ 1.20
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-01-2024 12-31-2023 10-K
3 11-06-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 07-29-2021 06-30-2021 10-Q
13 04-28-2021 03-31-2021 10-Q
14 02-18-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 03-02-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-01-2019 12-31-2018 10-K
23 11-09-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 03-01-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-01-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 05-11-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-07-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-opko-health-maintains-3-price-target

HC Wainwright & Co. analyst Yi Chen reiterates OPKO Health (NASDAQ:OPK) with a Buy and maintains $3 price target.

 opko-health-q1-2024-gaap-eps-012-misses-010-estimate-sales-173700m-miss-182990m-estimate

OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) ...

 hc-wainwright--co-reiterates-buy-on-opko-health-maintains-3-price-target

HC Wainwright & Co. reiterates OPKO Health (NASDAQ:OPK) with a Buy and maintains $3 price target.

 barrington-research-maintains-outperform-on-opko-health-maintains-15-price-target

Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and maintains $1.5 price ta...

 why-kodiak-sciences-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-e...

 labcorp-expands-diagnostic-reach-with-strategic-deal-for-select-assets-of-bioreference-health

Labcorp acquires certain operations of Opko Health subsidiary BioReference Health. The assets Labcorp is acquiring generate abo...

 rex-american-resources-reports-upbeat-earnings-joins-avalo-therapeutics-rh-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corpo...

Core News & Articles

Transaction to enhance Labcorp's laboratory services network and expand access to the company's high-quality clinical l...

 modex-therapeutics-an-opko-health-company-announces-results-from-a-phase-1-clinical-study-of-sar441236-its-trispecific-broadly-neutralizing-antibody-against-hiv-at-the-2024-conference-on-retroviruses-and-opportunistic-infections

• Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in ...

 immunic-and-2-other-stocks-under-2-insiders-are-buying

The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their conf...

 hc-wainwright--co-reiterates-buy-on-opko-health-maintains-3-price-target

HC Wainwright & Co. analyst Yi Chen reiterates OPKO Health (NASDAQ:OPK) with a Buy and maintains $3 price target.

 barrington-research-maintains-outperform-on-opko-health-lowers-price-target-to-15

Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and lowers the price target...

 opko-health-q4-earnings-insights
OPKO Health: Q4 Earnings Insights
02/27/2024 21:25:11

 opko-health-q4-2023-gaap-eps-009-beats-010-estimate-sales-18190m-beat-17753m-estimate

OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by...

 earnings-scheduled-for-february-27-2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

 opko-healths-earnings-outlook
OPKO Health's Earnings Outlook
02/26/2024 18:01:47

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION